A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at Rest

NCT00288730 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure, Congestive
Heart Decompensation

Interventions

DRUG: nesiritide

Sponsor

Scios, Inc.